This article introduces a multi-step preparative purification workflow for synthetic peptides using liquid ...

This important study shows that the Nora virus, a natural Drosophila pathogen that also persistently infects many laboratory fly stocks, infects intestinal stem cells (ISCs), leading to a shorter life ...

The fourth pair of denosumab biosimilars, Conexxence and Bomyntra, are expected to launch in the United States in mid 2025, ...

The FDA has approved Tremfya (guselkumab) for the treatment of adults with moderately to severely active Crohn disease.

The U.S. Consumer Product Safety Commission has issued an urgent recall on this liquid allergy medication that could pose a ...

The data presented support use of MR vaccine at 6 months to protect young infants during measles outbreaks and in settings ...

Similarly, in GALAXI 3, 47% in the guselkumab group had clinical remission at week 12 vs 15% with the placebo ... and in a single-dose prefilled syringe (100mg/mL, 200mg/2mL), single-dose ...

Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgen's Prolia and Xgeva for review.

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

The dramatic moment Thai police tasered a tourist during a “rampage” in his Phuket hotel room has been captured on video.

This should not shift the focus of the potential health hazard posed, but rather draw attention to where volatile PFAS are ...